Sentences with phrase «share price growth for»

Enterprise to drive growth With 34 % of total revenue, the enterprise and infrastructure business is a key driver of earnings and share price growth for Jabil.

Not exact matches

The Sunnyvale, Calif. company's lucrative piece of the Chinese e-commerce company (BABA) has done wonders for its coffers and share price but lately has sent it into an existential crisis as investors seek growth from the beleaguered company.

Collect a Check When stock price growth is sluggish, dividends account for a much bigger share of investors» gains.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

But growth is the main driver for M&A deals: Not just growth in drug distribution scale or earnings growth through cost - cutting, but in revenues — and especially share price.

The company's financial performance in the year to date has been mixed after its decision to raise the prices of its products weakened its market share and forced it to trim its sales growth forecast for the full year.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

But anyone hoping for the kind of stock growth Shoppers enjoyed over the past decade — when its share price climbed from less than $ 18 to, at one point, over $ 55 — will be disappointed.

At its current valuation of ~ $ 67 / share, HLF has a price to economic book value ratio (price - to - EBV) of 1.2 That ratio means that the market expects only 20 % growth in NOPAT for the remainder of HLF's existence.

At its new price of ~ $ 23 / share, the market expects 10 % compounded annual NOPAT growth for the next 11 years.

Figure 1 shows this value - destroying behavior in action for GE (GE) by comparing between the amount of money spent buying back shares and the price to economic book value (PEBV), a measure of the growth expectations embedded in the stock price.

While the $ 2.36 per share offer only implies a «small» 15 per cent takeover premium to Deutsche's $ 2.05 price target, the research team points to «recent operational risks in the hospital portfolio, the execution risks of the Northern Beaches greenfield project and our lower revenue growth outlook for the private hospital industry.»

With consistent profit growth, strong free cash flow, and the opportunity for share price appreciation, Brocade Communications Systems (BRCD) is this week's Long Idea.

In 2015, news reports revealed that Uber had an operating loss of $ 470 million on $ 415 million in revenue, confirming suspicions that the company has been bleeding money for the sake of achieving steep growth and acquiring market share.391 In China, the company has lost more than $ 1 billion a year.392 The strategy of aggressive price competition and brazen leadership coupled with soaring growth prompted immediate comparisons to Amazon.393 Like Amazon, Uber has drawn immense interest from investors.

Mac — in a declining PC industry, we expect Mac to continue its market share gain and support our forecast for its strong performance of 7.3 % revenue growth in FY 2015, followed by 3.6 % in FY 2016, and 4.6 % in FY 2017 on flat average selling prices over the three year period of $ 1,230.

For example, an investor that ponders the probability that a company will report a certain earnings growth rate over a five - or ten - year period is much more apt to ride out short - term fluctuations in the share price.

«Boards that authorise share - repurchase initiatives at market prices below what the businesses are intrinsically worth per share (without foregoing investment in even more compelling growth opportunities and with due regard for the financial security of the remaining shareholders) are clearly putting the shareholder's interest high on the priority list» Frank Martin

While these network effects have generated enormous revenues, today's glamour stocks also trade at earnings and price / revenue multiples that have historically been reserved for companies at a much earlier point in their growth trajectories, not for mature companies with already overwhelming market share.

Business growth is just beginning to catch up with share price for Shake Shack.

If you solve for»n' such that the present value of the cash flows is equal to the share price you get an indication of the growth rate implied in the stock price.

FedEx still offers an earnings growth rate that is high for large companies, yet we were able to purchase shares at prices that were first seen in 2003, even though earnings per share have more than doubled over the period.

For the safety of stable growth, you often give up some return so don't expect the share prices to shoot higher in any given year.

The current stock price (~ $ 33 / share) implies over about 12 % growth in profits compounded annually for about 10 years.

Some of this difference is driven by slightly different growth factors; for example, VONG looks at book - to - price ratios, medium - term growth forecasts and historical sales - per - share growth, while IWY only uses the latter two factors.

Medium Risk — Growth (M / GRW) Lower to average risk equities of companies with sound financials, consistent earnings growth, the potential for long - term price appreciation, a potential dividend yield, and / or share repurchase prGrowth (M / GRW) Lower to average risk equities of companies with sound financials, consistent earnings growth, the potential for long - term price appreciation, a potential dividend yield, and / or share repurchase prgrowth, the potential for long - term price appreciation, a potential dividend yield, and / or share repurchase program.

«The later stages of the 2009 — 2017 bull market are a valuation illusion built on share buyback alchemy... The technique optically reduces the price - to - earnings multiple because the denominator doesn't adjust for the reduced share count... Share buybacks are a major contributor to the low volatility regime because a large price insensitive buyer is always ready to purchase the market on weakness... Share buybacks result in a lower volatility, lower liquidity, which in turn incentivizes more share buybacks, further incentivizing passive and systematic strategies that are short volatility in all their forms... Like a snake eating its own tail, the market can not rely on share buybacks indefinitely to nourish the illusion of grshare buyback alchemy... The technique optically reduces the price - to - earnings multiple because the denominator doesn't adjust for the reduced share count... Share buybacks are a major contributor to the low volatility regime because a large price insensitive buyer is always ready to purchase the market on weakness... Share buybacks result in a lower volatility, lower liquidity, which in turn incentivizes more share buybacks, further incentivizing passive and systematic strategies that are short volatility in all their forms... Like a snake eating its own tail, the market can not rely on share buybacks indefinitely to nourish the illusion of grshare count... Share buybacks are a major contributor to the low volatility regime because a large price insensitive buyer is always ready to purchase the market on weakness... Share buybacks result in a lower volatility, lower liquidity, which in turn incentivizes more share buybacks, further incentivizing passive and systematic strategies that are short volatility in all their forms... Like a snake eating its own tail, the market can not rely on share buybacks indefinitely to nourish the illusion of grShare buybacks are a major contributor to the low volatility regime because a large price insensitive buyer is always ready to purchase the market on weakness... Share buybacks result in a lower volatility, lower liquidity, which in turn incentivizes more share buybacks, further incentivizing passive and systematic strategies that are short volatility in all their forms... Like a snake eating its own tail, the market can not rely on share buybacks indefinitely to nourish the illusion of grShare buybacks result in a lower volatility, lower liquidity, which in turn incentivizes more share buybacks, further incentivizing passive and systematic strategies that are short volatility in all their forms... Like a snake eating its own tail, the market can not rely on share buybacks indefinitely to nourish the illusion of grshare buybacks, further incentivizing passive and systematic strategies that are short volatility in all their forms... Like a snake eating its own tail, the market can not rely on share buybacks indefinitely to nourish the illusion of grshare buybacks indefinitely to nourish the illusion of growth.

Sluggish beverage growth in North America has helped to constrain the share price for the past year.

Based on the year - end 2016 price for the growth share being 10 % below average (63 % vs 70 %), this model suggests that stocks presently could be more attractive than usual.

China has been the strongest growth area for Treasury, whose share price has more than doubled in the past two years.

Coca - Cola Amatil has cut prices for its market - leading Mt Franklin brand to reduce the price gap with Asahi's Frantelle and Cool Ridge brands and Woolworths» private - label water, in an attempt to regain market share and volume growth.

In a statement quoted by Barrons.com, the bank said that Treasury, which had seen its market share in China grow over the last three years, was priced for «unrealistically high volume growth in China, at peak price points and peak margins».

$ 8 billion) over first ten years for deficit reductionObeys PAYGO; Starting in 2026, 25 % of auction revenues for deficit reductionFuels and TransportationIncrease biofuels to 60 million gallons by 2030, low - carbon fuel standard of 10 % by 2010, 1 million plug» in hybrid cars by 2025, raise fuel economy standards, smart growth funding, end oil subsidies, promote natural gas drilling, enhanced oil recoverySmart growth funding, plug - in hybrids, raise fuel economy standards $ 7 billion a year for smart growth funding, plug - in hybrids, natural gas vehicles, raise fuel economy standards; offshore drilling with revenue sharing and oil spill veto, natural gas fracking disclosureCost ContainmentInternational offsetsOffset pool, banking and borrowing flexibility, soft price collar using permit reserve auction at $ 28 per ton going to 60 % above three - year - average market price» Hard» price collar between $ 12 and $ 25 per ton, floor increases at 3 % + CPI, ceiling at 5 % + CPI, plus permit reserve auction, offsets like W - MClean Air Act And StatesNot discussedOnly polluters above 25,000 tons of carbon dioxide equivalent a year, regional cap and trade suspended until 2017, EPA to set stationary source performance standards in 2016, some Clean Air Act provisions excludedOnly polluters above 25,000 tons of carbon dioxide equivalent a year, regional cap and trade pre-empted, establishes coal - fired plant performance standards, some Clean Air Act provisions excludedInternational CompetitivenessTax incentives for domestic auto industryFree allowances for trade - exposed industries, 2020 carbon tariff on importsCarbon tariff on importsReferences: Barack Obama, 2007; Barack Obama, 8/3/08; Pew Center, 6/26/09; leaked drafts of American Power Act, 5/11/10.

For example, consider the following figure that compares how the growth estimates from four different models are related to the school share of students who are eligible for free or reduced price lunchFor example, consider the following figure that compares how the growth estimates from four different models are related to the school share of students who are eligible for free or reduced price lunchfor free or reduced price lunches.

The Defendants» purpose in adopting the agency model was to end competitive pricing for ebooks, and to slow the growth of ebooks in general, and the growth of Amazon's dominant market share in particular.

For dividend growth investors, they offer a rare opportunity to buy shares of a high quality dividend grower at a bargain price.

In the latest Stock Pickers Digest, we take a close look at the company's growth plans, and the outlook for oil and gas, and see what they could mean for its share price.

ROYAL BANK OF CANADA $ 105 (Toronto symbol RY; Conservative Growth and Income Portfolios, Finance sector; Shares outstanding: 1.5 billion; Market cap: $ 157.5 billion; Price - to - sales ratio: 3.9; Dividend yield: 3.5 %; TSINetwork Rating: Above Average; www.rbc.com) acquired Los Angeles - based City National Bank in November 2015 for $ 5.5... Read More

A momentum investor generally looks not just for growth but for accelerating growth that is attracting a lot of investors and causing the share price to rise.

For instance, they may want to see a p / e ratio (the ratio of a stock's price to its per - share earnings) below 15.0, along with an earnings growth rate of 20 % or more a year, and perhaps a 2 % dividend yield.

Friess Associates is a growth - oriented manager driven by individual company research that seeks to isolate companies with fundamental profiles that position them for share price appreciation.

A valuation metric for determining the relative trade - off between the price of a stock, earnings generated per share (EPS), dividend yield and the company's expected growth.

Take, for example, the following chart, which shows both the earnings - per - share (EPS) growth and the price performance of the MSCI World Growth and MSCI World Value indices during the first six months ofgrowth and the price performance of the MSCI World Growth and MSCI World Value indices during the first six months ofGrowth and MSCI World Value indices during the first six months of 2017.

For instance, they may want to see a p / e ratio (the ratio of a stock price to its per - share earnings) below 15.0, say, along with an earnings growth rate of 20 % or more annually, and perhaps a 2 % dividend yield.

The growth rate needs to be pretty good to be acquiring shares each month regardless of share price (you can always halt auto - purchases for a time being if you think the price gets too high for a season).

This should mean continues strong distribution growth among MLPs as an asset class — and higher prices for MLP shares.

Canadian marijuana stocks may move higher on momentum — but they need significant revenue growth to justify their huge market caps Share prices for many Canadian marijuana stocks have soared since mid-2016.

The price - earnings ratio based on forecasted earnings for the next fiscal year is no more than one - half the projected long - term growth rate in earnings per share

Growth - income funds, for example, tend to invest in Blue Chip companies that pay steady dividends but may also provide capital gains through share price appreciation.

If the company recovers and increases exponentially over the coming decades, those 7 shares will not participate in the growth of the stock price after the split event — you will only get the much lower cash - out amount for the shares.

True Religion Drops — Gualberto Diaz believes the recent drop in share price in True Religion (TRGL) has created an opportunity for buying into an amazingly undervalued, high growth company.